Enanta Pharmaceuticals, Inc Share Price
NASDAQ: ENTAHealthcare
Live Enanta Pharmaceuticals, Inc Share Price Chart
O H L
Enanta Pharmaceuticals, Inc Performance Overview
Days Range
▼
$12.22Low
$12.57High
Markets Today
| Previous Close | $12.52 |
|---|---|
| Open | $12.57 |
| Volume | 41,851 |
| Day's Range | $12.22 - $12.57 |
| 52W Range | $7.05 - $17.15 |
| Market Cap | $369.89 M |
Historical Performance
| 1M Returns | -5.86 |
|---|---|
| 3M Returns | -1.11 |
| 6M Returns | -1.42 |
| 1Y Returns | +59.69 |
| 5Y Returns | -78.57 |
| 10Y Returns | -51.19 |
Enanta Pharmaceuticals, Inc Fundamentals
| Market Cap | $369.89 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $65.32 M |
| ROE TTM | -0.85 |
| EPS TTM | $-2.41 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.66 |
| EBITDA | $-80.76 M |
| Profit Margin | -125.36 |
| Market Cap | $369.89 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $65.32 M |
| ROE TTM | -0.85 |
| EPS TTM | $-2.41 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 3.66 |
| EBITDA | $-80.76 M |
| Profit Margin | -125.36 |
Enanta Pharmaceuticals, Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $14.93 M | $18.31 M | $15.13 M | $18.61 M | $17.16 M | $14.36 M |
| Gross Profit + | $14.93 M | $18.31 M | $15.13 M | $18.61 M | $17.16 M | $14.36 M |
| Operating Income | -$24.53 M | -$18.89 M | -$18.39 M | -$11.25 M | -$11.85 M | -$17.24 M |
| EBITDA | -$23.32 M | -$17.68 M | -$17.10 M | -$10.02 M | -$10.64 M | -$16.05 M |
| Interest Expense | -$1.71 M | -$1.62 M | -$2.39 M | -$3.08 M | -$3.32 M | -$4.13 M |
| Depreciation | $1.20 M | $1.21 M | $1.28 M | $1.23 M | $1.21 M | $1.19 M |
| Income Before Tax | -$23.95 M | -$18.23 M | -$18.67 M | -$11.91 M | -$13.08 M | -$19.46 M |
| Income Tax Expense | -$1.30 M | $29.00 K | $32.00 K | $24.00 K | $7.00 K | $36.00 K |
| Net Income + | -$22.64 M | -$18.25 M | -$18.70 M | -$11.94 M | -$13.09 M | -$19.50 M |
| Net Profit Margin | -151.71% | -99.68% | -123.64% | -64.13% | -76.29% | -135.81% |
Enanta Pharmaceuticals, Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $214.00 K | $214.00 K | $214.00 K | $290.00 K | $291.00 K | $291.00 K |
| Reserve & Surplus | -$368.20 M | -$386.63 M | -$405.27 M | -$417.20 M | -$430.69 M | -$450.39 M |
| Non-Current Liabilities | $183.51 M | $177.20 M | $167.46 M | $158.18 M | $151.68 M | $141.64 M |
| Current Liabilities | $45.95 M | $44.55 M | $48.55 M | $44.73 M | $46.44 M | $54.17 M |
| Total Liabilities | $229.46 M | $221.75 M | $216.01 M | $202.91 M | $198.12 M | $195.80 M |
| Fixed Assets | $37.57 M | $36.62 M | $35.40 M | $34.31 M | $33.11 M | $31.94 M |
| Current Assets | $242.86 M | $222.71 M | $204.34 M | $198.68 M | $178.41 M | $203.62 M |
| Total Assets | $322.99 M | $301.03 M | $280.73 M | $329.50 M | $314.70 M | $296.87 M |
Enanta Pharmaceuticals, Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$22.64 M | -$18.25 M | -$18.70 M | -$11.94 M | -$13.09 M | -$19.50 M |
| Operating Cash Flow | -$13.49 M | $17.51 M | -$6.49 M | -$11.70 M | -$7.16 M | -$9.97 M |
| Investing Cash Flow | -$4.37 M | -$26.48 M | $2.30 M | -$47.30 M | $11.94 M | $14.01 M |
| Financing Cash Flow | -$6.89 M | -$6.42 M | -$8.32 M | $64.14 M | -$7.29 M | -$5.54 M |
| Change in Cash | -$24.74 M | -$15.40 M | -$12.51 M | $5.14 M | -$2.51 M | -$1.51 M |
Enanta Pharmaceuticals, Inc Return Calculator
The Enanta Pharmaceuticals, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$2,102
Invested Amount$10,000
Est. Returns$-7,898
About Enanta Pharmaceuticals, Inc
Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.
Popular Stocks
FAQs
What is the share price of Enanta Pharmaceuticals, Inc today?
Enanta Pharmaceuticals, Inc (ENTA) share price as of September 18, 2026 is $12.28. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Enanta Pharmaceuticals, Inc?
Yes, Indian Investors can invest in the Enanta Pharmaceuticals, Inc (ENTA) Share by opening an international trading account with Angel One.
How can I purchase Enanta Pharmaceuticals, Inc shares in India?
Purchasing Enanta Pharmaceuticals, Inc (ENTA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Enanta Pharmaceuticals, Inc (ENTA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Enanta Pharmaceuticals, Inc?
Yes, you can purchase fractional shares of Enanta Pharmaceuticals, Inc (ENTA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Enanta Pharmaceuticals, Inc?
The market capitalization of Enanta Pharmaceuticals, Inc on September 18, 2026, is $369.89 M.
In which sector Enanta Pharmaceuticals, Inc belongs?
Enanta Pharmaceuticals, Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Enanta Pharmaceuticals, Inc stocks?
In order to invest in Enanta Pharmaceuticals, Inc (ENTA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
